LGVN: Rasio silihan jangka dawa marang modal Longeveron Corporation

Lambang korporat lan logo Longeveron Corporation (LGVN)

The long-term debt-to-equity ratio demonstrates stable compliance with environmental standards for bio-waste disposal, with the indicator reaching 0.00. Longeveron Inc. revenues rely on insurance payouts and private equity for the treatment of age-related pathologies. The reduction of operational risks is ensured by in-house laboratories, which minimizes dependence on external drug production.

LGVN Longeveron Corp: Utang jangka dawa marang ekuitas ing interval 04.07.2022 - 31.10.2026
Produk mawa merek Longeveron Corp

This ratio is calculated as the sum of credit obligations with a maturity of more than one year divided by total equity. The metric determines the company's degree of reliance on borrowed funds for long-term financing. For Longeveron Inc. (LGVN) and its capital-intensive Lomecel-B developments within the biotech sector, this balance is critically important. By analyzing this long-term debt load chart, an investor assesses the platform's resilience to market shocks. Low leverage here confirms financial autonomy.